Theratechnologies (NASDAQ:THTX) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Theratechnologies (NASDAQ:THTX - Get Free Report) released its earnings results on Thursday. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.03, Yahoo Finance reports. The company had revenue of $22.60 million for the quarter. During the same period last year, the firm posted ($0.03) EPS. Theratechnologies updated its FY 2024 guidance to EPS.

Get Theratechnologies alerts:

Theratechnologies Price Performance

THTX traded down $0.01 on Friday, hitting $1.26. 106,720 shares of the stock were exchanged, compared to its average volume of 45,518. Theratechnologies has a 12 month low of $0.88 and a 12 month high of $2.58. The firm has a market capitalization of $57.70 million, a price-to-earnings ratio of -6.61 and a beta of 1.41. The business has a 50-day moving average of $1.28 and a two-hundred day moving average of $1.34.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

Should you invest $1,000 in Theratechnologies right now?

Before you consider Theratechnologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.

While Theratechnologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report